Scientists identify overactive genes in aggressive breast cancers: Potential new drug target for hard-to-treat ‘triple-negative’ tumors

Scientists have identified an overactive network of growth-spurring genes that drive stem-like breast cancer cells enriched in triple-negative breast tumors, a typically aggressive cancer that is highly resistant to current therapies.